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Abstract
Immunosuppression is a characteristic feature of Toxoplasma gondii-infected murine hosts. The present study aimed to
determine the effect of the immunosuppression induced by T. gondii infection on the pathogenesis and progression of
Alzheimer’s disease (AD) in Tg2576 AD mice. Mice were infected with a cyst-forming strain (ME49) of T. gondii, and levels of
inflammatory mediators (IFN-c and nitric oxide), anti-inflammatory cytokines (IL-10 and TGF-b), neuronal damage, and b-
amyloid plaque deposition were examined in brain tissues and/or in BV-2 microglial cells. In addition, behavioral tests,
including the water maze and Y-maze tests, were performed on T. gondii-infected and uninfected Tg2576 mice. Results
revealed that whereas the level of IFN-c was unchanged, the levels of anti-inflammatory cytokines were significantly higher
in T. gondii-infected mice than in uninfected mice, and in BV-2 cells treated with T. gondii lysate antigen. Furthermore, nitrite
production from primary cultured brain microglial cells and BV-2 cells was reduced by the addition of T. gondii lysate
antigen (TLA), and b-amyloid plaque deposition in the cortex and hippocampus of Tg2576 mouse brains was remarkably
lower in T. gondii-infected AD mice than in uninfected controls. In addition, water maze and Y-maze test results revealed
retarded cognitive capacities in uninfected mice as compared with infected mice. These findings demonstrate the favorable
effects of the immunosuppression induced by T. gondii infection on the pathogenesis and progression of AD in Tg2576
mice.
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Introduction
Toxoplasma gondii (T. gondii) is a protozoan parasite that
commonly infects humans and animals [1]. Humans are generally
infected by ingesting oocysts released in cat feces or by consuming
undercooked meat containing tissue cysts. Following ingestion,
bradyzoites and sporozoites released from cysts and oocysts invade
intestinal cells and convert to tachyzoites [1], which when
disseminated via blood or the lymphatic system to remote organs
induce acute or chronic inflammatory responses. Furthermore,
during the chronic stage, the brain is the most commonly affected
site [2]. T. gondii is a serious pathogen that can invade vital organs,
but usually the infection is mild and asymptomatic in immuno-
competent hosts. Possible clinical manifestations include lymph-
adenopathy, myocarditis, hepatitis, sepsis syndrome, retinocho-
roiditis, and encephalitis [1]. However, normally the infection
becomes chronic, remains latent in the brain, and elicits life-long
immunity against toxoplasmosis [1].
Immune responses to T. gondii infection differ during the
proliferative (acute phase) and dormant (chronic and latent phase)
stages and depend on the virulence of the parasite strain, for
example, RH is a highly virulent strain (type I) whereas ME49 is
avirulent (type II). The acute phase is characterized by marked
elevations in serum Th1 cytokine levels, such as, of IFN-c, TNF-a,
IL-12, and IL-18, and is followed by a lethal outcome in mice. On
the other hand, non-lethal infection is characterized by modest
elevations in Th1 cytokine levels that led to the control of T. gondii
infection and minimal damage to the host [3]. In particular, ME49
is an avirulent strain that can exist in the brain for a considerable
time by suppressing immune responses in the central nervous
system (CNS) [3,4]. During the course of T. gondii infection, the
levels of anti-inflammatory cytokines, like IL-10 and TGF-b,
increase in brain tissues, whereas the productions of inflammatory
mediators, such as, nitric oxide (NO), decrease [4,5,6]. Further-
more, these anti-inflammatory responses may prevent tissue injury
and establish a chronic state of host-parasite equilibrium [4,5,6].
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mation is not a common finding in the brains of mice chronically
infected with T. gondii [7]. Similarly, chronic or latent infections by
infectious agents in the CNS may delay the onset of neurodegen-
erative changes related to nerve inflammation [8]. Regarding
neuroinflammation in T. gondii infection, NO production is known
to be an important regulator and indicator. For example, NO
production was found to be significantly down-regulation when
conditioned medium of a T. gondii-infected astrocyte culture was
added to a microglia culture [7], which suggests that the immune
responses triggered by T. gondii infection can reduce inflammatory
response in the host brain and prevent neuronal degeneration.
The neuronal degeneration induced by neuroinflammation is
known to play a key role in the pathogenesis of chronic
neurodegenerative diseases [9,10], and in particular, Alzheimer’s
disease (AD) is the most common cause of dementia in the elderly
causing progressive and permanent reductions in learning,
memory, and cognitive abilities [10]. The pathogenesis of AD is
characterized by widespread neuronal degeneration, involving
synaptic and neuronal loss, and the formations of extracellular
neuritic plaques containing b-amyloid peptides and intracellular
neurofibrillary tangles [10]. Histologically, AD brain tissues show
increased numbers of reactive microglia [11], which when exposed
to inflammatory stimuli express the inducible form of NO synthase
(iNOS), and thus, increase NO production [12]. Moreover,
adjacent neuronal cells are extremely susceptible to the toxic
effects of NO, and this sensitivity plays a central role in the
pathogenesis of neurodegenerative diseases [12,13].
Microglial cells also augment inflammatory responses by
releasing various mediators, such as, cytokines, reactive oxygen
species, complement factors, neurotoxic secretary products, and
free radicals [7,8,9,10,11,12,13,14,15], and many of these
mediators are known to stimulate amyloid precursor protein
(APP) deposition and contribute to neuronal death in AD
[7,8,9,10,11,12,13,14,15]. Eventually, microglial cell activation
can establish a vicious cycle of inflammatory mediator release and
the stimulation of APP production [15]. In this respect, we
considered that it would be interesting to probe the relationship
between host immune response against the long-lived and latent
pathogen T. gondii in the brain and the progression of age-related
neurodegenerative disorder.
Investigations on the possible link between T. gondii infection
and degenerative central nervous system (CNS) disease in man
have been mainly limited in the serology testing of T. gondii-specific
antibody [16,17,18]. Recently, such studies have been conducted
in AD patients, PD patients, and patients with other psychiatric
conditions. For example, in one study, the seropositivity rate for T.
gondii-specific IgG was found to be more in patients with AD than in
healthy controls (44.1% versus 24.3%) [16]. In another study, 42
patients with obsessive-compulsive disorder (OCD) and 52 patients
with Parkinson’s disease (PD) alsoshowed significantly higher titers in
seropositivity than controls [17,18]. As a result, the authors suggested
that T. gondii infection may be involved in the pathogenetic
mechanisms of CNS diseases [16,18]. However, in those study the
anti-T. gondii IgG titers shows IgG levels examined at that time, and
thus, do not suggest that a causal relationship exists between
toxoplasmosis and the etiology of psychiatric illness and dementia
[19]. Because the causal relationship between toxoplasmosis and the
etiology of CNS diseases cannot be simply determined, experimen-
tation is needed under known conditions, that is, with information on
times between infection and disease onset.
In the present study, we undertook to determine whether T.
gondii infection is involved in the neuroinflammation and
neurodegeneration mechanisms of dementia. We hypothesized
that latent T. gondii infection in the mouse brain may induce
immunosuppression to escape host immune attack, and thus, act to
suppress the pathogenesis of AD. Thus, the objective of the present
study was to investigate the effect of the inhibition of neuroin-
flammation by T. gondii on the progression of AD. For this
purpose, we used Tg2576 mice (an accepted model of AD)
infected with an avirulent strain (ME49). Degrees of neuronal
protection in brains were determined histologically, and immune
responses were examined in brain tissues and BV-2 microglial
cells. In addition, the water and Y-maze behavioral tests were used
to quantify learning and memory abilities and cognitive functions.
Results
T. gondii infection in Tg2576 AD mice inhibited neuronal
degeneration and induced IL-10 and TGF-b
To determine the neuronal damage caused by T. gondii infection,
histopathologic changes in the hippocampal region were examined
by hematoxylin and eosin (H-E) staining in Tg2576 AD mice
infected or not infected by T. gondii. As shown in Figure 1, neuronal
death (eosinophilic neurons) was remarkable in the hippocampal
region of phosphate-buffered saline (PBS)-treated uninfected mice
(Figure 1A, progressive AD mice as a control), whereas infected
Tg2576 mice (Figure 1B) and infected wild type mice (data not
shown) exhibited few eosinophilic neurons in the same region.
Progressive AD mice (TG+PBS) showed numerous dead neurons
((57.762.5)%) in the dentate gyrus at 9 months after birth
Figure 1. T. gondii infection inhibited spontaneous neuronal degeneration in Tg2576 AD mice. Histological changes in the hippocampal
formation of Tg2576 AD mice were observed by H&E staining, and changes in T. gondii-infected (B; ME49) and uninfected mice were compared (A;
PBS). Neuronal death, represented by eosinophilic neurons (PBS,6100), was remarkably lower in the hippocampal region of infected Tg2576 mice (B;
ME49) than in Tg2576 mice (A; PBS), which showed spontaneous neuronal degeneration (6100). Scale bar=100 mm. Results are represented as
percentages of degenerative cells among all cells in dentate gyrus of hippocampal formation (C).
doi:10.1371/journal.pone.0033312.g001
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showed relatively few dead neurons ((29.260.81)%) (Figure 1C)
Because neurodegeneration is related to immune balance
between inflammatory mediators and inflammation-suppressing
cytokines, the mRNA levels of IFN-c, IL-10, and TGF-b were
examined in T. gondii-infected Tg2576 mice by quantitative real-
time PCR (Figure 2A). IFN-c mRNA levels were found to be no
different in infected and uninfected Tg2576 mice, but IL-10 and
TGF-b mRNA levels were higher in infected mice than in
uninfected control mice (Figure 2A).
Because the anti-inflammatory cytokines, IL-10 and TGF-b, are
produced by microglial cells for neuroprotection after traumatic
injury or stroke [20], we examined the secretion of these cytokines
using T. gondii-infected Tg2576 mouse brain tissues (Figure 2B, C)
and BV2 cells (a microglial cell line; Figure 2E, F). IL-10 and
TGF-b cytokine levels were found to be significantly higher in
infected Tg2576 mouse brain tissues (TG+ME49) than in
uninfected control mouse tissues (TG+PBS) (p,0.05) (Figure 2B–
C). Furthermore, levels of IL-10 and TGF-b in BV2 cells cultured
in vitro were found to be increased remarkably by the addition of T.
gondii lysate antigen (TLA), which concurred with our findings in
T. gondii-infected mouse brains (Figure 2B–C).
When exposed to inflammatory stimuli, microglial cells produce
the inducible form of NO synthase (iNOS), and the NO
subsequently produced is critically required to construct protective
host responses against foreign pathogens. However, this immune
response eventually damages host tissues, and in particular, NO is
a key mediator of glia-induced neuronal death [12]. In the present
study, primary cultured microglial cells were prepared from wild
type mice (C57BL/6), and incubated with TLA, recombinant IL-
10, or recombinant TGF-b (Figure 2D). As was expected, 100 ng/
ml LPS increased nitrite production by cells, whereas the addition
of 50 mg/ml TLA, recombinant IL-10, or recombinant TGF-b
decreased nitrite production. Furthermore, the effect of TLA on
nitrite production was also observed in the presence of LPS
(Figure 2D). Microglial cells from primary cultured brain tissues
showed significantly less nitrite production when TLA was added,
and the addition of TLA decreased nitrite production under
conditions of LPS stimulation (Figure 2D).
Similarly, anti-inflammatory cytokines and NO levels were
measured after treating BV2 cells with TLA (Figure 2E, F, G). The
addition of LPS increased nitrite production by cells, whereas the
addition of TLA, IL-10, or TGF-b decreased nitrite levels
(Figure 2G). Observed decreases in nitrite production were similar
when cells were treated with TLA, IL-10, or TGF-b. However,
when they were co-treated with LPS, the reduced nitrite level
elicited by TLA was significantly greater than the levels elicited by
IL-10 and TGF-b (Figure 2G; p,0.05). The above results show
that the productions of anti-inflammatory cytokines (IL-10 and
TGF-b) and reduced nitrite production were observed under all
experimental conditions (T. gondii-infected Tg2576 mice and TLA
stimulated primary cultured microglia and BV-2 cells).
T. gondii infection inhibited b-amyloid plaque formation
in the cortex and hippocampus of Tg2576 mice
Previous reports have indicated that inflammatory mediators
stimulate amyloidogenesis in AD by inducing APP production and
b-secretase expression [15,21]. In the present study, we investi-
gated whether suppression of neurodegeneration and the anti-
inflammatory cytokine increase observed in T. gondii-infected
Tg2576 mice affect amyloidogenesis. The relationship between
infection and b-amyloid deposition was examined by Congo red
staining and immunohistochemistry in the brains of Tg2576 mice
using b-amyloid specific 6E10 antibody, which specifically
recognizes the 1–17 amino acid sequence of b-amyloid peptides
(Figure 3). Furthermore, whereas the brain tissues of wild type
mice did not contain b-amyloid plaques by Congo red staining
(Figure 3A1–2), Tg2576 mice typically generated considerable
amounts of amyloid plaque (Figure 3A3, 3B), but T. gondii-infected
Tg2576 mice exhibited obviously lower amounts of plaque
(Figure 3A4, 3B). We also evaluated b-amyloid protein deposition
by immunohistochemical (IHC) staining using 6E10 antibody
(Figure 3A5, 6, 7, 8). It was found extracellular b-amyloid plaques
in the cortex (Figure 3A5) and hippocampal region (Figure 3A7) of
uninfected Tg2576 mice were remarkably greater than in T. gondii-
infected Tg2576 mice (Figure 3A6, 3A8), and that the number of
plaques was significantly lower in T. gondii-infected Tg2576 mice
in both hippocampus and cortex (Figure 3B).
T. gondii infection attenuated learning and memory
impairments in Tg2576 mice
T. gondii infection was found to induce the productions of IL-10 and
TGF-b in brain and to suppress nitrite production in response to TLA,
indicating the local inductions of anti-inflammatory responses in brain.
In addition, b-amyloid plaque depositions were found to be reduced in
the cortex and hippocampus of infected mice. These findings raised the
question as to whether progressive impairments of learning and
memory in Tg2576 mice could be reduced by the anti-inflammatory
responses induced by T. gondii infection.
Based on these findings, we used the Morris water maze and the
Y-maze behavioraltests to quantify learning and memory functions,
as previously described [22]. In the water maze test, Tg2576 mice
infected with T. gondii were found to differ significantly from
uninfected (PBS-treated) mice (p=0.0055, F=4.49; Figure 4A).
However, no difference was found between T. gondii-infected and
uninfected wild type mice (Figure 4A). In the probe test at 48 hours
after final spatial training, T. gondii-infected Tg2576 mice stayed
significantly longer in zone 4 than in other zones (zones 1–3)
(Figure 4A). Mean durations in each zone for T. gondii-infected
Tg2576 mice in the water maze test were as follows; zone 4
(platform), 26.77 s; zone 1, 16.36 s; zone 2, 9.87 s; and zone 3,
6.98 s (Figure 4A). However, uninfected Tg2576 mice exhibited a
different pattern,suggesting loss ofmemory(zone 1,12.69 s;zone 2,
10.04 s; zone 3, 12.58 s; and zone 4, 11.97 s). This result was
confirmed by measuring the mean times required to reach the
platform (a measure of learning and memory) (Figure 4B), and by
investigating swimming paths in zone 4 during the last probe trial
(platform removed) (Figure 4C).
The Y-maze test was also conducted to evaluate learning and
memory functions, as described previously [23] (Figure 5). The success
rate of T. gondii-infected mice in the Y-maze test was significantly
greater than for uninfected mice (p,0.01, by one-way ANOVA and
Tukey’s post hoc test). Accordingly, Morris water maze and Y-maze
testing showed that T. gondii infection inhibited spontaneous memory
functional impairments in Tg2576 mice (Figure 5).
The passive avoidance test was performed to confirm the effect
of T. gondii infection on wild type and Tg2576 mice (Figure S1).
Times taken to enter the dark chamber (latencies) were measured
for 300 sec (retention trial). T. gondii-infected Tg2576 mice were
found to have greater latencies (Figure S1), which means the T.
gondii infection in AD model mice (Tg2576) inhibited memory
deterioration, as was observed for the Morris water maze and Y-
maze behavioral tests.
Discussion
T. gondii is a zoonotic protozoan that can infect many
vertebrates. It has a worldwide distribution, and is the causative
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survey conducted in the USA in 1988–1994, T. gondii seropreva-
lence in the overall age-adjusted population was 22.5%, and it
showed a gradual increase with age [24]. Furthermore, France and
several other European countries, Latin America, and sub-Saharan
Africa have even higher seroprevalences than the USA [25].
T. gondii has two developmental stages in man, that is,
tachyzoites (trophozoites during acute infection) and bradyzoites
(cysts during chronic infection), and these have different
pathogenic consequences [2]. Tachyzoites disseminated via blood
or the lymphatic system to different organs during acute stage
disease cause toxoplasmosis, which is characterized by lymphade-
nopathy and reticular cell hyperplasia [2]. However, during the
chronic, latent stage, the brain is the most commonly affected [2].
Furthermore, during this stage, the infection is likely to be
accompanied by nerve degeneration, which progresses with age.
In this respect, T. gondii is an important infectious agent during the
course of neuronal degenerative diseases, such as, AD. However,
the relationships between chronic, latent T. gondii infection and
age-related neuronal degenerative diseases have not been
determined. Since most cases of primary T. gondii infection are
asymptomatic and the parasite has established immune privilege in
chronically infected host tissues, such as, in the brain [2], the
relationships between neurodegenerative diseases, such as, AD,
and T. gondii infection have been overlooked.
T. gondii is classified into three clonal lineages by virulence [3].
The type I genotype is highly virulent to mice, whereas the
lethalities of the type II and III strains are substantially lower.
Type II strains, which include ME49, are highly prevalent in
animals, and are also associated with toxoplasmosis in man [3].
The lethality of T. gondii in mice is largely determined by strain
genotype. Lethal infections are mediated by a strong Th1 cytokine
response, such as, by IFN-c, IL-12, TNF-a, and IL-18, whereas
non-lethal type II ME49 infections are controlled by the modest
inductions of Th1 cytokines [3]. The overstimulation of host
immune responses that are normally required for protection is an
important immunological feature in acute toxoplasmosis [3]. In
contrast, during latent infections, T. gondii contributes to the
control of host immune response in a manner that results in
immunosuppression [5,7,26]. In fact, several in vitro studies have
shown that T. gondii triggered immune responses reduce
inflammatory responses and prevent neuronal degeneration
[5,7]. Thus, the reduction of neuroinflammation by immune
modulation could alter the disease onset and progression of AD
[9,10,12,13,14,15]. However, although the authors of these
reports suggested that T. gondii infection in the brain reduces
neuroinflammation, the effects of T. gondii infection in the
development of neurodegenerative disorders, such as, AD, have
not been examined.
In recent studies, it has been found that more than 40% of
patients with a severe CNS disease have anti-T. gondii IgG
[16,17,18]. In a Turkish study of such patients, T. gondii infection
was screened for based on seropositivity against T. gondii
immunoglobulin regardless of symptom onset. Accordingly, results
would be interpreted to mean that psychiatric and dementia
patients have life styles that differ from those of healthy controls
[19], for example, patients with impaired social and occupational
functions are more likely to stay at home, and if they owned cats,
would be at greater risk of being exposed to T. gondii [19]. Thus the
causal relationship between toxoplasmosis and the etiology of
certain CNS diseases, such as, dementia, cannot be easily
determined [19]. To overcome these types of problems associated
with human research, animal research is required because it can
provide information regarding temporal relations between infec-
tion and disease onset.
In the present study, we focused on the effects of chronic, latent
Toxoplasma infection in the brains of Tg 2576 mice on
neurodegenerative changes and inflammation induced genetically.
Histopathologic studies showed that the hippocampal region of
non-infected Tg 2576 mice exhibited many eosinophilic b-amyloid
peptide plaques, and showed that these plaques were less present
in the brains of T. gondii-infected Tg2576 mice or wild type mice.
These results convince us that the neuroprotection observed was
due to T. gondii infection. Furthermore, our results also suggest that
the neuroprotective effects of T. gondii extend to learning and
memory impairments in Tg2576 mice and possibly to the
progression of AD.
In the CNS, microglial cells, astrocytes, and neurons are
susceptible to T. gondii infection, and in chronic infections, latent
cysts are produced in the CNS [27]. Although microglial cells are
largely responsible for preventing T. gondii proliferation in the
brain, they also sometimes produce the anti-inflammatory
cytokine IL-10, and facilitate parasite persistence by suppressing
immune responses in the CNS [28,29]. IL-10 is produced mainly
by brain mononuclear cells, and inhibits the productions of IL-12,
IL-6, IFN-c, and TNF-a, suggesting that IL-10 has an ameliora-
tive effect on the severe inflammation caused by toxoplasmic
encephalitis [30].
Notably, an intraperitoneal injection of lipopolysaccharide
(LPS), an inflammation inducing endotoxin, was found to result
in memory impairments in mice [31]. In addition, repeated
injections of LPS enhanced b-amyloid generation, and conversely,
treatment with anti-inflammatory agents suppressed LPS-induced
amyloidogenesis, memory dysfunction, and neuronal cell death
[31]. In this study, it was also found that inflammation resulted in
an accumulation of b-amyloid 1–42 via increased b- and c-
secretase activities accompanied by elevated APP expression and
astrocyte activation [31].
In the AD brain, various neuroinflammatory mediators,
including complement activators and inhibitors, chemokines,
cytokines, radical oxygen species, and inflammatory enzyme
systems, are released by microglia, astrocytes, and neurons [15].
Figure 2. T. gondii induced an inflammation-suppressing immune environment in vivo and in vitro. (A) The mRNA expressions of
inflammation-suppressing cytokines (IL-10 and TGF-b) were higher in T. gondii (Me49)-infected Tg2576 mice than in their uninfected littermates (A).
mRNA levels are presented as percentages of cytokine levels in infected mice versus uninfected mice. Furthermore, IL-10 and TGF-b cytokines were
significantly higher in the brain tissues of infected mice than in those of uninfected mice (P,0.05) (B & C). Nitrite levels suggested the production of
nitric oxide (NO), an inflammatory mediator related to neuronal death. Primary cultured microglial cells were prepared from wild type mice (C57BL/6
mice) and tested for nitrite production (D). Microglial cells cultured from brain tissues showed a significant decrease in nitrite production when TLA or
anti-inflammatory cytokines were added (D). To investigate the possibility that these cytokines were produced by microglial cells, BV-2 cells were
cultivated with LPS and/or T. gondii lysate antigen (TLA) (E & F). BV-2 microglia treated with TLA significantly increased the productions of IL-10 (E)
and TGF-b (F) in the presence or absence of LPS. BV-2 cells were incubated for 12 h in the presence of TLA, LPS, IL-10, or TGF-b, and the supernatants
obtained were analyzed for nitrite (G). The results obtained showed that nitrite concentrations were lower in TLA-, IL-10-, or TGF-b-treated cells than
in non-treated control cells. In particular, the nitrite concentration increase induced by LPS was significantly lowered by co-treatment with TLA
(P,0.05).
doi:10.1371/journal.pone.0033312.g002
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TGF-b, are required to prevent immunopathological effects by
inhibiting the chemotactic migrations of these microglial cells
toward b-amyloid aggregates and by directly inducing anti-
inflammatory responses [15,32]. Convincing evidence shows that
Th2 cytokines have beneficial immunomodulatory effects in
toxoplasmosis [28,29,30]. Actually, IL-10 is known to play vital
roles in the control of inflammatory responses during acute
toxoplasmosis, and to inhibit tissue damage during the chronic
phase [28,29,30]. Furthermore, the high susceptibility of IL-10-
knockout mice to T. gondii infection has been shown to be
mediated by an exacerbated inflammatory process not caused by
parasite proliferation [33]. The inflammation process is an
important countermeasure to infection, but it also damages host
tissues. In the long term, harmful inflammations may be
eliminated by pathogen’s strategy to inhibit host cellular immunity
[28,29,30]. T. gondii provides a good example of this effect.
In the present study, T. gondii was found to induce an anti-
inflammatory effect by up-regulating IL-10 and TGF-b. Further-
more, in vitro treatment of primary microglial cells and BV-2 cells
with TLA reduced NO production, which is known to play
important roles during neuroinflammation and the pathogenesis of
AD. Furthermore, inflammation in the brain may be an important
component of the mechanism of dementia and cognitive decline in
the elderly. Accordingly, it has been suggested that the inhibition
of inflammatory cascades may attenuate amyloidogenic processes,
such as, those of AD [34]. Furthermore, because the suppression
of NO synthesis was found to prevent cell death and restore
lymphocyte proliferation in T. gondii (ME49)-infected mice [4], our
results support the notion that the inhibition of neuroinflammation
by T. gondii attenuates the progression of amyloidogenesis in
Tg2576 mice.
TGF-b1 and IL-10 are important cytokines that can induce
tolerance and suppress exaggerated immune response. In
particular, in one study, elevated levels of TGF-ß1 were found
to be related to amyloid plaque reductions in the parenchyma,
hippocampus, and neocortex of the hAPP Tg mouse brain, and to
reduced levels of dystrophic neuritis in aged hAPP Tg mice [35].
Similarly, a decrease in TGF-b signaling in cultured neuroblas-
toma cells was found to cause neuronal degeneration and to
increase levels of secreted Ab and b-secretase-cleaved soluble APP
[36].
Our results also show that T. gondii-infected Tg2576 mice
exhibited higher levels of the anti-inflammatory cytokines, IL-10
and TGF-b, in brain tissues, and less neuronal death, amyloid
plaque deposition, and neurodegeneration than non-infected mice.
In one previous study, it was found that T. gondii-triggered immune
regulations, which included prostaglandin E2 secretion by
Figure 3. Deposition of beta-amyloid plaque in the brains of mice with or without T. gondii infection. Differences between b-amyloid
deposit levels in T. gondii-infected and non-infected mice (PBS-treated mice) were examined in the cortex and hippocampus regions using Congo red
and by immunohistochemical staining with 6E10 antibody. Congo red staining was performed on; uninfected (PBS-treated) wild type (A1), T. gondii-
infected wild type (A2), uninfected Tg2576 (A3), and infected Tg2576 (A4) mouse groups. Wild type mice with or without T. gondii infection showed
no amyloid plaque (A1, A2) at 9 mo after birth, whereas PBS-treated Tg2576 mice showed many Congo red-stained regions in the cortex (A3).
However, no amyloid plaque was observed in T. gondii infected Tg2576 mouse brain tissues (A4). Immunostaining results of cortex and hippocampus
concurred with Congo red findings (A5, A6, A7, A8). (640, Scale bar=200 mm).). In addition, numbers of plaques in cortex and hippocampus were
counted using a color digital camera attached to a microscope and Image J software, and the results obtained showed that numbers of plaques were
significantly less in the hippocampus and cortex of T. gondii-infected Tg2576 mice (B).
doi:10.1371/journal.pone.0033312.g003
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reduced NO production, and as a result, the authors suggested
that T. gondii reduced tissue inflammation in the host brain [7]. An
in vivo study also demonstrated a remarkable increase of IL-10
expression in the brains of T. gondii-infected mice [37]. In the
present study, T. gondii antigen decreased NO production by
primary cultured microglia and BV-2 cells, which also suggests
that T. gondii prevented neuron degeneration in Tg2576 AD model
mice.
One interesting observation made in the present study was that
T. gondii infection attenuated impairments in learning and memory
functions in Tg2576 mice, as demonstrated by the water- and Y-
maze tests. Furthermore, these results well matched with the
observed reduction in NO production and the expressional
upregulations of anti-inflammatory cytokines. It is known that
Tg2576 mice exhibit an increase in ß-amyloid deposition and
memory loss at the time of the appearance of detergent-insoluble
ß-amyloid aggregates (ß-amyloidinsol) 6 months after birth [22]. In
the present study, T. gondii-infected Tg2576 mice were found to
retain the memory capacities of non-AD wild type mice (control
mice) according to water- and Y-maze test results. In this respect,
our findings agree with those of other investigators, who found that
C57BL/6 mice infected with the avirulent ME49 strain showed
normal cognitive behaviors despite widespread brain pathologies
and sensorimotor deficits [38].
The present study demonstrates effects of chronic, latent T.
gondii infection on progressive neurodegenerative disease in an AD
transgenic mouse model, whereas previous studies has been
performed at the early infection stage (within 2 months of
infection) [3,4,28,29,37]. The age of the mice used in the present
study and the infection period seem to be more relevant, because
T. gondii has a long latency period in the host brain [1]. Thus, our
results describe the long-lasting (at least 6 months after infection)
effects of T. gondii infection on mice. In addition, our study
highlights the possibility that the neuroprotection induced by T.
gondii infection before the onset of AD could inhibit the b-amyloid
accumulation and neurodegeneration that probably diminish
cognitive abilities. Furthermore, we suggest that our results, which
obtained using a mouse AD model, are helpful in terms of
determining the relationship between T. gondii infection and
human AD, because most cases of human toxoplasmosis are
caused by genotype II, to which ME49 used in the present study
belongs [39,40].
Materials and Methods
Experimental Animals
Tg2576 mice (an established animal model of AD) expressing
the mutated human APP695 gene [41] were obtained from
Taconic (German Town, NY, USA) and were bred by mating
male mice with (C57BL6/SJL) F1 females as recommended by
suppliers and as described by others [42,43]. The genotyping was
performed by confirming the presence of the human APP695
transgene by PCR analysis of genomic DNA in the mouse tail tips.
Figure 4. Evaluation of learning and memory using the Morris water maze test. Differences in learning and memory between wild type
(WT) and Tg2576 mice (TG) at 9 mo of age were examined using the Morris water maze test. (A) In a 60 s probe trial, the ability of uninfected (PBS-
treated)-Tg2576 mice (TG+PBS) to find the training quadrant (zone 4, which contained the platform) was significantly less than those of mice in the
other experimental groups (A; p,0.0001). On the other hand, T. gondii-infected Tg2576 mice (TG+ME49) performed as well as wild type mice (B).
Representative swimming paths of mice during the probe trial (platform removed) were as follows (C); TG+PBS mice seemed unaware of the platform
position, whereas TG+ME49 mice and wild-type mice (WT+PBS and WT+ME49) remained in the vicinity of the platform. The yellow box in the figure
indicates the hidden platform.
doi:10.1371/journal.pone.0033312.g004
Effect of T. Gondii Infection in Tg2576 Mice
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33312A pair of primers for detecting human APP695 and PCR
condition was as follows. Forward (59- CTGACCACTCGACCA
GGTTCTGGGT-39) and reverse (59- GTGGATAACC
CCTCCCCCAGCCTAGACCA -39) primers amplified a 466-
bp DNA fragment. The reaction conditions used were; initial
denaturation at 94uC for 10 min, 35 amplification cycles
[denaturation at 94uC for 1 min, annealing at 55uC for 30 s,
and elongation at 72uC for 1 min], followed by one cycle at 72uC
for 5 min. Tg2576 mice over-expressing human APP695 contain-
ing the ‘‘Swedish’’ mutation have memory deficits and show
progressive ß-amyloid plaque deposition with age [42]. Because
these mice exhibit a rapid increase in ß-amyloid at around 6
months after birth and the formation of amyloid plaque before 6–9
months, they represent a suitable animal model for examining
relationships between ß-amyloid and memory [42].
Ethics Statement
This study was carried out in strict accordance with the
Guidelines for Animal Experiments issued by the Ethics
Committee at Seoul National University. The study protocol
was approved by the Committee on the Ethics of Animal
Experiments at Seoul National University (Permit Number:
SNU-080625-1). All surgeries were performed under anesthesia,
and all efforts were made to minimize animal suffering.
T. gondii infection
T. gondii, ME49 strain, was maintained by injecting cysts isolated
from the brains of infected C57BL/6 mice (Orient Bio Animal
Center, Seongnam, Gyeonggi-do, Korea) intraperitoneally. To
infect Tg2576 mice, the brains of mice infected with ME49 strain
were harvested at 3 months post-infection and minced to isolate
cysts. Cysts were then isolated under a microscope and 15 were
inoculated intraperitoneally into each experimental mouse. Infected
micewereraised under SPF conditions at Seoul National University
College of Medicine. All behavioral experiments were conducted at
6 months post-infection in 9-month mice, which were then
sacrificed for histological examinations and cytokine analysis.
Water-maze Test
The experiment was conducted using a circular water tank
(140 cm in diameter, 45 cm high) filled with 21–23uC water
opacified with dry milk powder. The tank contained an invisible
platform placed 1.5 cm below the surface of the water. Prominent
extra-maze cues were provided to aid platform location. Data were
automatically collected using a computerized motion analyzer
(Ethovision, Noldus Information Technology H.V., Wageningen,
The Netherlands). For descriptive data collection, the pool was
subdivided into four equal imaginary quadrants; a video analyzer
was used to produce images of swimming animals. Preliminary
spatial training was conducted using five time trials of 60 s per
trial. During each training session, times taken to find the platform
were recorded. Forty-eight hours after the final trial, a spatial
probe trial was conducted in the same tank with the platform
removed. Mice were allowed to swim for 60 s. Times spent and
path lengths in the target quadrant were recorded. Data were
automatically analyzed using a video image motion analyzer
(Ethovision).
Y-maze Test
Spatial memory was also assessed using the Y-maze test. The
apparatus used consisted of a black plastic maze with three arms
that intersected at 60u (60 cm long, 15 cm high, and 10 cm wide).
Vertical metal poles located at the outer perimeter of the maze
provided spatial cues. A mouse was placed at the end of one arm
and allowed to move freely through the maze for 8 min without
reinforcements, such as, food and water. The total numbers of
entries into arms, including returns to same arms, were recorded.
Alternation was defined as entry into each of the three arms
consecutively. The maximum number of alternations was
calculated by subtracting two from the total number of arms
entered. Percent alternation was calculated by expressing actual
alternations as a percentage of maximum alternations. Y-maze
behavior test groups were as follows; uninfected wild type (n=10),
infected wild type (n=5), uninfected Tg2576 (n=9), and infected
Tg2576 (n=10) groups.
Congo red staining
Brain sections (10 mm) were deparaffinized and then hydrated
using a descending ethanol series. After washing in distilled water,
sections were incubated in a freshly prepared, alcoholic, saturated
alkaline sodium chloride reagent (2.5 mM NaOH in 80% alcohol)
for 20 min at room temperature. Slides of sections were stained
with 0.4% Congo red (W/V) in an alcoholic, saturated alkaline
sodium chloride reagent (freshly prepared and filtered just prior to
use) for 30 min at room temperature. Sections were washed in
distilled water, counterstained with methyl green for 5 min,
dehydrated using an ascending ethanol series, and treated three
times with 100% reagent-grade ethanol. Sections where then
treated with xylene and coverslipped with Permount (Fisher
Scientific Co., Pittsburgh, PA, USA).
Immunostaining of the pathology of Alzheimer’s disease
All animals were anesthetized with Zoletil (15 mg/kg) and
Rompun (5 mg/kg) and then perfused with a 4% paraformalde-
hyde solution for 20 min. Brain tissues were dehydrated through
an ethanol gradient, embedded in paraffin, and sectioned at
10 mm. Prior to immunostaining, sections on slides were
deparaffinized in an oven, immersed in xylene, and rehydrated
using an ethanol gradient. Antigen retrieval in paraffin-embedded
tissues was achieved by treating sections with citric acid (1.8 mM
citric acid and 8.2 mM sodium citrate) for 10 min and cooling to
room temperature. Thirty minutes later, sections were washed
with 0.05 M Tris-buffered saline (TBS) and incubated with
primary 6E10 antibodies in TBS containing 0.5% BSA and
0.5% Triton X-100 overnight at 4Cu. They were then washed
Figure 5. Evaluation of learning and memory using the Y-maze
test. Tg2576 and wild type mice with or without T. gondii infection
were tested. A significant difference in success rates was observed
between uninfected Tg2576 mice (Tg+PBS) and the other experimental
groups (WT+PBS, WT+ME49, Tg+ME49) (P,0.01).
doi:10.1371/journal.pone.0033312.g005
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antibodies (Vectastain Elite ABC kit; Vector Laboratories,
Burlingame, CA, USA) for 45 min at room temperature. Sections
were then reacted with avidin-biotin-peroxidase complex (Vectas-
tain Elite ABC kit) for 1 h; reactions were detected using 0.05%
3,3-diaminobenzidine tetrahydrochloride (DAB) as a chromogen
and 0.01% H2O2 in PBS. Sections were then dehydrated using an
alcohol series, cleared in xylene, and coverslipped using Canadian
balsam solution (Polysciences Inc., Warrington, PA, USA).
Peroxidase-stained sections were examined under a light micro-
scope (PM-20, Olympus, Tokyo, Japan).
To count amyloid plaques in the hippocampus and cortex,
photomicrographs were acquired using a color digital camera
DFC280 (Leica Microsystems, Wetzlar, Germany) attached to a
microscope (BX-51; Olympus). Numbers of amyloid plaques were
counted using Image J software (Version 1.45).
Hematoxylin and eosin staining
Brain tissues were embedded in paraffin and coronally sectioned
at 10 mm through the hippocampus, mounted, and stained with
hematoxylin and eosin. They were then dehydrated using a graded
alcohol series, cleared in xylene, and coverslipped in Canadian
balsam solution. Neuronal degeneration in hippocampus was
determined by detecting eosinophilic neurons under a light
microscope (Olympus PM-20; Olympus). To count degenerative
cells in the hippocampal dentate gyrus, photomicrographs were
acquired with a color digital camera DFC280 (Leica) attached to a
microscope (BX-51; Olympus). Degenerative cells were counted
using Image J software (Version 1.45).
Western blot analysis
Cultured BV-2 cells or brain tissues were homogenized in a
solution containing a protease inhibitor cocktail (Roche, India-
napolis, IN) using a potter-Elvehjem homogenizer (OMNI
International, Kennesaw, GA, USA). Homogenates were then
centrifuged at 1,000 g for 15 min. Proteins were separated by
SDS-PAGE and transferred to PVDF membranes, which were
then blocked with 5% skim milk in Tris-buffered saline (TBS) for
2 h. Protein bands were confirmed with 6E10 antibody to b-
amyloid peptide and horseradish peroxidase-conjugated secondary
antibody (Amersham Pharmacia, Buckinghamshire, UK), and
immunoreactive bands were visualized using an ECL enhanced
chemiluminescence system (ECL; Amersham Pharmacia, Buck-
inghamshire, UK). b-Actin and GAPDH were used as loading
controls.
Toxoplasma gondii lysate antigen
T. gondii lysate antigen (TLA) was prepared as previously
described with slight modification [44]. Briefly, tachyzoites of T.
gondii RH strain were obtained from the peritoneal exudates of
infected mice. Exudates were passed twice through a 25-gauge
needle and then through 5 mm filter membranes to remove debris
and host cells. Parasites were then washed, resuspended in
phosphate-buffered saline (pH 7.4), and sonicated on ice. The
supernatant (TLA) was filter-sterilized through a 0.22 mm
membrane, and the protein concentration in TLA was determined
using a Nanodrop (Thermo Scientific, Rockford, IL). TLA was
stored at 270uC until required.
In Vitro activation of BV-2 cells using recombinant
cytokines
The murine microglial cell line, BV-2, was cultured in
Dulbecco’s modified essential medium (DMEM; Applied Scientif-
ic, San Francisco, CA) containing 5% heat-inactivated fetal calf
serum (Hyclone, Ogden, UT), 4 mM L-glutamine, 0.2 mM
penicillin, 0.05 mM streptomycin, and 20 mM HEPES (Sigma,
St. Louis, MO) at 37uCi naC O 2 incubator [45]. Cells were then
washed twice with serum-free DMEM, and incubated for 6 or
24 h in 96 well culture plates (SPL Lifescience, Pocheon-si,
Gyeonggi-do, Korea) in 100 ng/ml lipopolysaccharide (Sigma),
20 ng/ml IL-10 (PeproTech, Rocky Hill, NJ, USA), 20 ng/ml
TGF-b (Cell signaling, Danvers, MA, USA), or 50 mg/ml TLA (T.
gondii lysate antigen). Cells were then harvested for real-time PCR,
and culture supernatants were harvested for nitrite content
determinations and cytokine ELISA assays.
Real-time PCR
Total RNAs from brain tissue samples and BV2 cells were
isolated using RNeasy kits (QIAGEN, Hilden, Germany); all
samples were reverse transcribed using RT premix (Intron,
Sungnam, Korea). Real-time PCR was performed using the iQ5
real-time PCR detection system (Bio-Rad, Hercules, CA) and
SYBR green was used to detect amplification products, as
described previously [43]. The reaction conditions used were;
initial denaturation at 95uC for 10 min, 40 amplification cycles
[denaturation at 95uC for 10 s, annealing at 56uC for 30 s, and
elongation at 72uC for 30 s], followed by one cycle at 72uC for
5 min. Data analysis was performed using iQ
TM5 optical system
software (Bio-Rad). Primer sequences used for GAPDH, IFN-c,
TGF-b, and IL-10 are shown in Table S1.
Preparation of primary cultured microglia
Microglial cells were prepared from the primary cultures of
mouse brains as previously described [46]. Briefly, mixed glial cell
cultures were prepared from postnatal day 1–3 C57BL/6 mice.
Meninges were removed from cerebral hemispheres, prepared into
single cells by trituration, and incubated in glial cell culture
medium (DMEM supplemented with 10 mM HEPES, 10% FBS,
2 mM L-glutamine, and 16 antibiotic-antimycotic) in 75-cm
2
flasks at 37uC in a 5% CO2 incubator. The medium was changed
every five days, and microglial cells were harvested from mixed
glial cultures on culture day 14. After shaking at 200 rpm for 3 h
on an orbital shaker, culture media were collected and centrifuged
at 800 g for 10 min. Microglia were plated in glial culture media
and 20 min later plates were washed with medium to remove
unattached astrocytes. The purity of microglia was routinely
monitored and was approximately 98.5% as determined by
staining with rabbit anti-Iba-1 antibody (1:1,000 Wako Pure
Chemical Industries, Osaka, Japan) (Figure S2).
Nitric oxide production by primary cultured microglia
and BV-2 cells
Culture supernatants of primary cultured or BV-2 microglial
cells were assayed for nitrite content, which reflects NO
production, using Griess reagent (0.1% naphthylethylene diamine
dihydrochloride and 1% sulfanilamide containing 2.5% phospho-
ric acid in equal volumes), as described previously [45].
ELISA
Cytokine levels were determined using cytokine ELISA kits
(Immuno-Biological Co., Ltd., Takasaki, Japan). Briefly, 100 mlo f
culture supernatant was added to 96 well plates individually coated
with primary antibody against each cytokine and incubated
overnight at 4uC. After washing, 100 ml of labeled antibody
solution included in the ELISA kit was added and incubated for
1h ra t4 uC in the dark. After washing, the chromogen provided in
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room temperature in the dark. Stop solution was then added and
the intensities of color reactions were measured at 450 nm using a
microplate absorbance reader (TECAN, Ma ¨nnedorf, Switzerland).
Passive avoidance task
The passive avoidance task determines the ability of a mouse to
remember a foot shock and to avoid learned stimuli [43]. Briefly,
apparatus used consisted of a shuttle box divided into two
chambers of equal size, one illuminated and one dark, and both
equipped with a grid floor. Training begins by placing a mouse in
the light chamber opening the door to the dark chamber
20 seconds later. Because most mice prefer the dark chamber,
experimental mice quickly enter the dark chamber. Training was
repeated until the rats entered the dark compartment within
20 sec (training trial). After the training period, when a mouse
entered the dark chamber, the door closed automatically and the
mouse was delivered an electric foot shock (0.3 mA, 100 V, 3 s)
after all four limbs had entered the dark chamber (acquisition
trial). For actual testing, a mouse was placed in the light
compartment 24 h after the acquisition trial and the time taken
to enter the dark chamber (latency) was measured for 300 sec
(retention trial). The following animal groups underwent passive
avoidance testing; uninfected wild type (n=10), uninfected
Tg2576 (n=10), and infected Tg2576 (n=12) groups.
Statistical Analysis
Data are presented as means 6 SEMs. One-way ANOVA with
Tukey’s post-hoc test was used to assess differences between
experimental groups. Statistical significance was accepted for p
values of ,0.05.
Supporting Information
Figure S1 The passive avoidance test was used to
confirm the effect of T. gondii infection on memory
and behavior in wild type and Tg2576 mice. Time to enter
the dark chamber was measured for 300 sec (retention trial). The
time taken for T. gondii-infected Tg2576 mice (TG+ME49) was
greater than that taken by uninfected Tg2576 mice (TG+PBS).
(TIF)
Figure S2 Primary cultured microglia obtained from
mouse brain. The purity of microglia used in this study was
approximately 98.5% as determined by staining with rabbit anti-
Iba-1 antibody.
(TIF)
Table S1 Primers used for qPCR.
(TIF)
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